title: Antisense strategy in malignant brain tumours treatment.
authors.affiliation: School of Medicine, Case Western Reserve University, Cleveland, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Trojan
authors.forename: Y
authors.initials: Y
authors.lastname: Pan
authors.forename: A
authors.initials: A
authors.lastname: Szpechcinski
authors.forename: A
authors.initials: A
authors.lastname: Ly
authors.forename: P
authors.initials: P
authors.lastname: Kopinski
authors.forename: L
authors.initials: L
authors.lastname: Chyczewski
authors.forename: H
authors.initials: H
authors.lastname: Kasprzak
authors.forename: A
authors.initials: A
authors.lastname: Donald
authors.forename: J
authors.initials: J
authors.lastname: Trojan
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy*; D004337:Drug Carriers; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008081:Liposomes; D009447:Neuroblastoma / Q000188:drug therapy; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D016376:Oligonucleotides, Antisense